Biocure Technology Inc.
BICTF
$0.0014
$0.000216.67%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.20K | 41.00K | 46.90K | 615.50K | 38.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.20K | 41.00K | 46.90K | 615.50K | 38.70K |
| Operating Income | -1.20K | -41.00K | -46.90K | -615.50K | -38.70K |
| Income Before Tax | -6.60K | -14.70K | -17.60K | -2.92M | -84.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.60K | -14.70K | -17.60K | -2.92M | -84.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -26.80K | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 2.10K | -- |
| Net Income | -6.60K | -14.70K | -17.60K | -2.95M | -84.40K |
| EBIT | -1.20K | -41.00K | -46.90K | -615.50K | -38.70K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.33 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.04 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.33 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.04 | 0.00 |
| Average Basic Shares Outstanding | 81.60M | 9.07M | 10.32M | 9.05M | 90.71M |
| Average Diluted Shares Outstanding | 81.60M | 9.07M | 10.32M | 9.05M | 90.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |